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ABSTRACT 
Purpose: To investigate the clinical usage of dose verification of Helical Tomotherapy plans by using 2D-array ion 
chambers, and to develop an efficient way to validate the dose delivered for the patients during treatments. Materials 
and Methods: A pixel-segmented ionisation chamber device, IMRT MatriXX™ and Multicube™ phantom from IBA 
were used on ten selected Tomotherapy IMRT/IGRT head and neck plans in this study. The combined phantom was set 
up to measure the dose distribution from coronal and sagittal planes. The setup of phantom was guided for verifying the 
correction position by pre-treatment Tomotherapy MVCT images. After the irradiation, the measured dose distributions 
of coronal and sagittal planes were compared with those from calculation by the planning system for cross verification. 
The results were evaluated by the absolute and relative doses as well as Gamma (γ) function. The feasibility of the 
different measuring methods was studied for this rotational treatment technique. Results: The dose distributions 
measured by the MatriXX 2D array were in good agreements with plans calculated by Tomotherapy planning system. 
The discrepancy between the measured dose and predicted dose in the selected points was within ±3%. In the 
comparison of the pixel-segmented ionisation chamber versus treatment planning system using the 3 mm/3% γ-function 
criteria, the mean passing rates of 2 mm dose grid with γ-parameter ≤1 were 97.37% and 96.91%, in two orthogonal 
planes (coronal and sagittal directions), respectively. Conclusion: MatriXX with Multicube is a new system created for 
rotational delivery quality assurance (QA) and found to be reliable to measure both absolute dose and relative dose 
distributions, simultaneously. It achieves the goal of an efficient and accurate dosimetry validation method of the helical 
delivery pattern for the Helical Tomotherapy IMRT planning. © 2010 Biomedical Imaging and Intervention Journal. All 
rights reserved. 
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INTRODUCTION 
With the development and combined utilisation of 
Intensity Modulated Radiation Therapy (IMRT) and 
Image-Guided Radiation Therapy (IGRT) for the past 
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few years, forms of Helical Tomotherapy and advanced 
Intensity Modulated Arc Therapy (IMAT) have been 
evolving into new kinds of rotating radiation treatment 
techniques after step-and-shoot and sliding window 
IMRT deliveries. With the improvement of the beam 
entry angles and modulation parameters, it is obvious 
that rotational therapy will become an important delivery 
methodology in modern radiation oncology departments 
for better dose conformality and critical organ sparing. 
One of the important characteristics of rotating radiation 
is its dynamic nature and dosimetry variability in 
radiation delivery. Therefore, this is a great challenge for 
clinical physicists currently seeking tools to achieve 
quality assurance (QA) goals of this dynamic treatment 
planning and its associated delivery issues.  
Radiochromic film has been proven as a viable tool 
for quantitative 2D dosimetry for conventional and 
IMRT modalities for quite some time [1-13]. The 
greatest advantage of film dosimetry is its fine spatial 
resolution. However, film dosimetry is somewhat 
influenced by the limiting factors which are time-
consuming, uncertainties of developing-chemicals, and 
tedious analysing process. Pre-treatment patient plan 
verification is a part of standard procedures for IMRT 
treatment. No adequate solution has been available for 
the new dynamic techniques such as IMAT and 
Tomotherapy. Point-measurement with ionisation 
chambers is usually insufficient and film dosimetry 
requires a lot of work if clinical physicists try to achieve 
excellent agreements. Vendors who have provided the 
2D array detectors are all engaged in the new 
development for the verification of rotational dosimetry. 
Sun Nuclear has produced the MapPHAN™ along with 
its MapCHECK™ diode array to serve this purpose in 
acquiring the dose verification. Initial results are 
promising from multiple-angle testing. However, for 
lateral-entry beam angles, the phantom material buildup 
with detector location creates certain levels of dosimetric 
uncertainties. If a proper phantom material calibration is 
applied, then the dosimetry data are quite comparable to 
the EBT film dosimetry provided by International 
Specialty Products (Wayne, NJ, U.S.A.). With the new 
design specification, the rotational-treatment delivery 
verification using a 2D matrix detector to acquire 
rotational dosimetry data was described in detail [14]. 
PTW has also introduced the OCTAVIUS™ phantom for 
the QA of rotational treatment, along with their 2D-array 
ion chamber matrix which is currently being used in the 
planar dose analysis. They also claimed that the signal 
acquired is independent of the beam angles [15]. A novel 
3D device Delta-4 (ScandiDos, Uppsaka, Sweden) has 
also been reported in acquiring the 3D dose maps for 
IMRT treatments, which claimed to be useful in the 
rotational dosimetry measurements. 
Herzen J et al. reported that the response of a 
MatriXX QA device is linear with dose and energy 
independent. The authors concluded that the detector is a 
suitable device for QA and 2D dose verifications for 
IMRT QA [16]. The same QA device has also been 
investigated for proton therapy QA by the group from 
MD Anderson Cancer Center [17]. Their MatriXX 
measurement results on different energies of proton 
therapy beams were with the accuracy comparable to 
those of ion chamber measurements and film dosimetry. 
More recently, Li JG et al. compared the two 
commercially available detector arrays (MapCHECK
TM 
and MatriXX) for their use in the QA of patient-specific 
IMRT treatment plans [18]. Both detectors showed 
negligible errors (< 1%) when measuring doses of more 
than ~8 cGy, but exhibited errors of ~3% when 
measuring doses on the order of 1 cGy. The authors 
obtained excellent passing rates for both detector arrays 
when compared with the planar dose distributions from 
the treatment planning system for three 6 MV IMRT 
fields and three 18 MV IMRT fields. For the verification 
of rotational delivery, such as Tomotherapy or 
volumetric modulated arc therapy, the MapPHAN™ was 
developed for new or existing MapCHECK users. 
In this article, the authors utilised the newest 
development, MatriXX phantom with the 2D ion 
chamber arrays, from IBA (Louvain-Ia-Neuve, Belgium) 
to evaluate the most difficult head and neck treatment 
cases at the authors' center. The methodology mentioned 
in this article was different from the conventional QA 
verification procedure which only achieved the fixed 
beam entry angle of LINAC with planar dose distribution 
[19]. This particular verification system is created to 
assess 2D array suitability for rotational dosimetry. This 
QA study was performed for ten-patient plans from 
Helical Tomotherapy, with proper buildup and geometry 
for side scattered compensation. This 2D MatriXX 
device then transformed into a pseudo 3D tool for 
various plan verification in order to conquer the complex 
helical nature of radiation delivery.  
MATERIALS AND METHODS 
This QA phantom composed of MatriXX and 
Multicube was positioned on the treatment couch, 
verified with isocenter alignment tool provided by 
Tomotherapy planning and the laser systems. The 
irradiation source used for verification process is a single 
energy photon beam of 6 MV on a linear waveguide. 
MatriXX device consists of 1020 (32x32) vented pixel 
ion chambers. Each chamber occupies 0.08 cm
3 volume 
and holds the resolution of 7.62 mm. If multiple readings 
are generated, then 1 mm resolution with interpolation is 
applicable. Measurement dose rate ranges from 0.1 to 
20 Gy/min with the dose resolution of 0.5 mGy/min. All 
verification plans in this study were created for this 
phantom on Tomotherapy planning station, with version 
2.2.4. Measurement software provided by IBA dosimetry 
is OmniPro-IMRT version 1.6.  
Acquisition of the phantom images for verification 
The pixel ionisation chamber MatriXX was inserted 
into the Multicube phantom in order to form a complete 
assembly with a proper buildup, similar to the setup 
layout for dose verification picture on the couch of 
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Tomotherapy system as shown in Figures 1a and 1b. The 
assembly images for coronal and sagittal orientations of 
the combined phantom were previously scanned by a 
Philips Brilliance Big Bore CT simulator (Philips 
Medical Systems) and stored as a phantom data set. A 
2 mm slice thickness was used to guarantee the precision 
of 2D dose distribution calculated by Tomotherapy 
planning system, and also to maintain the exported 
intensity map iso-tropically for alignment purpose. The 
suitable locations to place the three fiducial marks were 
the pre-designed crosshairs on the MatriXX’s enclosures. 
This helps easily identify the center of the device on the 
phantom images acquired by the CT scanner. While 
generating the CT DICOM data set, the user has to make 
sure the phantom images are named accordingly for 
proper patient-specific identification. After the proper 
configuration and entry of basic information, images of 
combined phantom along coronal and sagittal 
orientations were then imported into Tomotherapy 
planning station for calculation of all patients in this 
study. 
Dose Verification  
Tomotherapy Delivery QA (DQA) setup 
First, after importing the pre-scanned CT images of 
the combined phantom for the corresponding setup, the 
image value-to-density table (IVDT) for the dose 
converting parameters is imported simultaneously for 
dose calculation. Secondly, the CT couch was removed 
from the phantom images and was replaced by the 
Tomotherapy delivery couch so that the different 
geometry effect of the couch was accurately modeled 
during the dose calculation process. According to the 
patient image volume, register the phantom images and 
save the laser positions to the DQA plan for setup 
correlation. Isocenter location is then properly 
determined. At the end, the dose distribution was 
calculated for the phantom image volume for each 
specific patient based on the final calculated and 
deliverable plan. The dose intent of the phantom 
planning should be identical as the prescribed dose to the 
patient per fraction from the final approved plan. 
Systematic measurement preparation 
Warm-up time of MatriXX 2D-Array ion chamber 
usually takes at least 15 minutes, as it is required before 
true delivery starts. Similar to other 2D-Array ion 
chamber devices available for clinical usage, a total dose 
of 100 cGy was pre-irradiated on the MatriXX array in 
order to eliminate noises and to keep the uniform dose 
response characteristic with better signal-to-noise range. 
This pre-irradiation procedure of IBA MatriXX array 
specially created for Tomotherapy system was 
automatically moving the couch longitudinally into the 
bore while maintaining 5x40 cm MLC opening at the 
static position at 0 degree. This method will keep the 
2D-Array ion chamber irradiated uniformly with 
minimum noise differentiation of the delivery dose 
responses. For the absolute dose calibration, there are 
two possible ways to perform this task. A typical 
calibration field was delivered at the dmax point to cross 
calibrate the central ion chamber, which represents 
1 cGy/MU with the C-arm LINAC. This method can be 
performed with a conventional LINAC on site and cross 
comparison has to be executed in measuring the 
Tomotherapy calibrated dose. Another method is to use 
the Tomotherapy static QA procedures to deliver known 
doses to the associated ion chamber locations, thus 
obtaining the corresponding calibration factors to the 
specific ion chamber (at least the center ion chamber 
needs to be cross checked).  
According to the experiments performed by Tim 
Holmes, Ph.D. [20], the directional dependence of this 
MatriXX system is quite acceptable for rotational 
delivery. The 1020 ion chambers are configured in a way 
   
(a) (b) 
Figure 1  Pictures of IMRT MatriXX 2-D Array and Multicube phantom clinical setting used to measure the 
Tomotherapy IMRT plan from two orthogonal orientations – (a) coronal, and (b) sagittal – respectively. 
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that very little high Z metal is present in the radiation 
field and the calculation is very accurate 
(convolution/superposition dose model). Rotational 
delivery can tolerate relatively larger errors over small 
angles. With 51 beam entries, even a single lateral beam 
contributes 10% dose error, which will only translate into 
0.2% total dose error. Geometrical blurring is also 
inherited in the rotational delivery, hence errors 
occurring over small distances are blurring out. An 
anterior avoidance plan has been delivered to verify the 
lateral beam angle dependence by Tomotherapy and 
MatriXX - results indicated that the passing rate of a 
lateral beam entrance plan is 93.54%, which has proven 
this device has minimum lateral beam entrance effect in 
Tomotherapy delivery. (Figure 3) 
Verification measurement for Tomotherapy IMRT 
plan 
The phantom plans for ten randomly selected 
patients with the coronal and sagittal directions were 
designed and saved into the data server for validation. 
These selected patients are all Nasopharyngeal 
Carcinoma (NPC) patients with patient 9 and 10 being 
the most challenging cases with a sharp dose gradient 
through the cord, brainstem and parotid glands while the 
tumor location is critically located in between. The 
reason for selecting head and neck cases is because such 
cases consist of the best testing modality for the rigidity 
of MatriXX for QA. Also, head and neck cancers are 
often very difficult to deal with. Another reason is that 
head and neck cases are the most common cancers in the 
authors’ areas which need IMRT treatments, and also 
present a tough choice for QA methodology. Before the 
delivery of the DQA plans, the set-up positioning as well 
as the laser alignment configuration are demonstrated as 
Figures 1a and 1b. Set-up accuracy of combined 
phantom location was corrected and confirmed by using 
planning CT/MVCT registration process, which is a 
standard procedure at the Tomotherapy operational 
console. During the pre-treatment IGRT process, 
Multicube and BBs are the areas that need to be covered 
by the MVCT scan, typically we use fine scan for the 
alignment purposes. If the laser and couch sag are 
properly managed, then the manual shift is not necessary 
because the auto-registration of Tomotherapy program 
functions well with MVCT images of MatriXX and its 
associated CT scans. After finishing the MVCT image 
registration, MatriXX within the combined phantom was 
irradiated according to verification plans generated from 
each selected patient in Tomotherapy planning console. 
Data analysis and processing after image and dose 
acquisition 
Two methods were implemented separately in order 
to analyze and compare the measurement data after 
Tomotherapy delivery. The dose distributions measured 
by the 2D-Array ion chamber were compared with those 
calculated by Tomotherapy DQA plans using vendor 
provided software tools.  
OmniPro-IMRT analysis software (from IBA) 
After data is exported from the Tomotherapy 
planning station, the intensity map file of dose 
calculation results was imported into OmniPro-IMRT 
software and co-registered with the measured dose 
intensity map. The proper file to send from Tomotherapy 
for export into OmniPro-IMRT software is the Text 
DQA Header and Image Files. These are files created by 
Tomotherapy for export. Those two files usually can be 
transferred via network or even a simple USB drive to 
the MatriXX computer with installed analysis program. 
After completion of file transfers, these two files were 
compared by using 2 mm and 1 mm calculation grid 
points. 3 mm/3% DTA and absolute dosimetry errors, as 
Gamma (γ) criteria [21, 22] are also used for evaluating 
the dose distribution on both the coronal and sagittal 
directional planes. The results of the quantitative and 
qualitative analysis were compared simultaneously for 
the specific phantom setup. 
Tomotherapy DQA software (from Tomotherapy) 
Tomotherapy planning tool also provides the 
evaluation software for dosimetry analysis. While the 
TIF image with registration points designed specifically 
for Tomotherapy was exported from MatriXX data, the 
linear CAL file for film calibration would be given 
automatically. After the acquisition process of MatriXX 
data, one can export the TIF file with registration points 
designed specifically for Tomotherapy. This will deliver 
the TIF image and a linear CAL file for film calibration. 
This particular functionality in OmniPro-IMRT version 
1.6 software is located under the “Export files” tab. The 
procedure for registering the TIF image in the DQA 
workspace was the same as using for a regular film-
based dosimetry. The comparison between measured and 
calculated dose distributions was also done by the 
3 mm/3%  γ-criteria, which calculated the gamma 
histogram to display those associated parameters in a 
real-time mode. 
RESULTS 
Dose verifications for ten pre-selected Tomotherapy 
NPC IMRT plans were performed in both coronal and 
sagittal orientations using the 2D MatriXX ion chamber 
device. Dose distribution between measured and 
calculated dose distribution showed good agreements 
from the data analysis. Figure 2 shows the percentage 
deviation of absolute dose distribution of the ten 
previously treated patients, which is shown within ±3% 
error margin. Selection criteria of points for absolute 
dose measurement was situated in the high dose and low 
gradient region of MatriXX measurement plane, 
according to the IMRT measurement guidelines in the 
AAPM Task Group report #119. 
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(a) (b) 
   
(c) (d) 
Figure 3  MatriXX directional sensitivity planning and measurement validation. (a) Target contours, (b) Planned, 
(c) Planned and measured isodose lines, (d) Statistics [20]. 
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OmniPro-IMRT software process 
Table 1 lists the results of Gamma analysis 
(3%/3  mm) with 2 mm and 1 mm calculation grids, 
respectively, for the selected 10 NPC patients. The 
average passing rates for the DTA of 3%/3 mm for the 
coronal plane at 2 mm and 1 mm grids are 97.37% and 
98.71%, respectively. And those for the sagittal plane are 
96.91% and 97.86%, respectively. Figures 4(a)-4(e) and 
5(a)-5(e) show the results of calculated and measured 
dose distributions and Gamma analysis (3%/3 mm) for a 
typical NPC plan along the coronal and sagittal direction. 
In Figure 5, the same NPC patient shown in Figure 4 is 
selected for analysis with the different plane (sagittal). 
The isodose matches and Gamma plot were displayed, as 
well as the statistical analysis. The passing rate is more 
than 90% with great confidence level of clinical 
implementation. 
Tomotherapy DQA analysis 
Although the Tomotherapy dosimetry analysis 
software does not provide passing rates for the dose 
distribution, in the Tomotherapy DQA process, dose 
fluence (profile) and histogram of the combined 3% and 
3 mm gamma criteria could still be analysed. Figures 
6(a)-6(c) and 7(a)-7(c) show the dose distribution and the 
Gamma results for the plan along the coronal and sagittal 
setup direction. And 6(d) and 7(d) show the Gamma 
histograms, with two directional setups. 
DISCUSSION 
Clinical example in Figure 4 shows a typical NPC 
patient with bilateral PTV coverage and the critical 
component for IMRT is cord sparing. Coronal 
planned/measured dose comparison using MatriXX and 
Multicube has shown excellent agreement, with passing 
rate 92.93% of 2 mm calculation grid. Gamma index plot 
also indicates only few areas are larger than 1.0. Figure 5 
shows the sagittal view of the same patient MatriXX 
evaluation; however, the passing rate has increased to 
94.82% with same dose grid calculation. The cord 
sparing of the measurement is very obvious and Gamma 
plot shows only few areas with the index larger than 1.0. 
Figures 6 and 7 are the reports generated from 
Tomotherapy evaluation tools with similar passing rates 
and the Gamma index plot, which has confirmed the QA 
device of MatriXX can be an excellent substitute of the 
film dosimetry due to the similar experimental results. 
The grid for dose calculation within Tomotherapy 
phantom plan was set at 2 mm and it was the same 
resolution as in the phantom planning and fan-beam CT 
scans. The 2 mm calculation grid was set in such a way 
that the longitudinal direction can match the CT scanning 
slices. Regarding the selection for the find grid for the 
dose calculation on the axial slice, the field of view is set 
at 512x512 to reach the maximum image resolution for 
calculation. In order to achieve the patient dose 
verification before the patient’ delivery, 2 mm on the 
calculation grid should be also used for registration 
purpose. Even though the passing rate with 1 mm grid 
was slightly higher than that with 2 mm, it would be 
better to select the 2 mm precision of dose calculation in 
these plans. 
Improvement of the MatriXX efficiency, compared 
to the regular Tomotherapy DQA procedures, the QA 
time has been cut down from 90 minutes film dosimetry 
to about 43 minutes for each patient DQA using 
MatriXX. Major time saving is from no marking and 
processing the film for measurement. Also, ion chamber 
of MatriXX reports the dose value immediately if 
properly calibrated, no separate ion chamber 
measurement setup is needed for point dose 
measurement. Tomotherapy represents a new approach 
of dynamic rotational IMRT with excellent image guided 
capability. Dose verification has been achieved by using 
the MatriXX 2-D array phantom along the coronal and 
sagittal directions for ten specific Tomotherapy patients. 
The analysis results for the absolute and relative doses 
between measured and calculated were found in 
excellent agreements. Therefore, the MatriXX is a 2D 
QA device, not only for dose verification of dynamic 
IMRT on conventional LINAC [23, 24], but also for 
helical Tomotherapy IMRT/IGRT treatment validation. 
Results of the measurement for two different setups have 
shown that the MatriXX on both directions are capable 
of generating superior clinical dosimetry results and 
extremely effective for measurements in helical 
Tomotherapy. The number of passing points with 
γ-parameter  ≤1 in coronal and sagittal direction also 
show excellent agreements with the final approved plans. 
Even with the tight margin and very complicated NPC 
cases, the authors still observed more than 90% passing 
rate. For instance, if the combined 5%/3 mm criterion 
was used for analysis, the number of points with γ≤1 
would increase to 94.37%. In addition, these results from 
two different analysis software (IBA and Tomotherapy) 
were very consistent. But if Tomotherapy DQA software 
is being utilised for the analysis, the counter clockwise 
setup along sagittal direction of the combined MatriXX 
phantom is recommended strongly for a better passing 
rate (Figure 1(b)). 
Chan et al. also reported that the diode array data 
showed a trend of angular dependence, decreasing from 
100% at 0º down to 90% at 80º gantry angle [25]; 
however, the overall measurement results from rotational 
delivery are within clinically acceptable accuracy due to 
the averaging effect from all the gantry angles [26]. 
Rotational delivery usually can tolerate larger errors in 
smaller angles, and the authors have observed the 
directional sensitivity of MatriXX ion chambers with 
water equivalent Multicube to less effect in the 
Tomotherapy delivery scheme. The MatriXX in 
Multicube phantom is ion chamber array system and it is 
well known that the angular dependence of ion chambers 
is not as severe clinically for rotational delivery. Planar 
dose validation device with buildup certainly presents the 
great challenge and that is the reason for SunNuclear to 
create a device called ArcCHECK™ to truly serve the 
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(a) (b)  (c) 
   
(d) (e) 
Figure 4  Analysis results between the measured and calculated dose at the 2 mm grid along the coronal direction. 





     
(a) (b)  (c) 
   
(d) (e) 
Figure 5  Analysis results between the measured and calculated dose at the 2 mm grid along the sagittal direction. 
(a) Measured dose, (b) Calculated dose, (c) Dose comparison, (d) Gamma plot, (e) Gamma analysis. 
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(a) (b) 
   
(c) (d) 
Figure 6  Comparison of measured and calculated results on the coronal measurement of MatriXX. (a), (b), (c) 
show the profile distribution and the Gamma results for the plan along the coronal setup (Isodose curve 
comparison, dose profile of the arbitrary surface, and gamma plot respectively). 6(d) is the Gamma 
histogram. 
 
   
(a) (b) 
   
(c) (d) 
Figure 7  Comparison of measured and calculated results on the sagittal measurement of Tomotherapy provided 
software. (a), (b), (c) show the profile distribution and the Gamma results for the plan along the saggital 
setup (Isodose curve comparison, dose profile of the arbitrary surface, and gamma plot respectively). 
6(d) is the Gamma histogram. 
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arc therapy dosimetry QA purpose. This is one of the 
first reports on patient-specific rotational dosimetry 
verification using MatriXX and Multicube. 
However, compared to the traditional film dosimetry, 
MatriXX is still a much easier device in clinics than the 
film-based QA program. In this study, the authors 
selected 10 NPC patients due to their sharp dose gradient 
and complexity, which bear the challenges to acquire 
superior agreement compared with simple prostate IMRT 
cases. This patient pool represents a challenging situation 
and the authors also observed good agreement with high 
passing rates in both coronal and sagittal planes.  
Similar to other commercial 2D-array, the effective 
field-size of 24.4×24.4 cm
2 of the MatriXX system 
presents some limitations (i.e., QA on large IMRT fields). 
But it should be a key issue for dose verification on most 
Tomotherapy IMRT plans. However, it's important to 
avoid irradiation of the electronic parts outside ion 
chamber so that it will not affect the lifetime of the QA 
device. On the other hand, the spatial resolution of 
MatriXX due to its structure is less than those of film for 
dose verification as obviously noticed. The area of high-
dose gradient should be further considered for data 
analysis. From the final study results, threading effect 
was inevitable in the helical Tomotherapy delivery 
process. With the development of hardware and software 
of commercial 2D-Array, it’s possible that dose 
verification using 2D-Array ion chamber could provide 
the cubic rotational dose reconstruction accurately. 
Weight of the combination of MatriXX and Multicube is 
another concern, the total weight is about 33 kg, which 
could also be cumbersome in transporting the phantom to 
and from the couch top. 
CONCLUSION 
MatriXX 2D-Array has provided a simple and 
effective dose verification tool for rotational dynamic 
IMRT such as Tomotherapy technique. The 
measurement for the final plans of Tomotherapy shows 
that MatriXX is capable of both absolute and relative 
dose measurements within good agreements. Its 
geometrical-machine buildup for the 2D array reduces 
uncertainties during the helical delivery in comparison 
with the Tomotherapy DQA dosimetry modules. 
MatriXX with Multicube phantom creates a smoother 
and efficient operation with reasonable QA analysis time 
and results for helical Tomotherapy at the authors’ busy 
cancer center.  
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